Search Results for keywords:"reference standards"

Found 3 results
Skip to main content

Search Results: keywords:"reference standards"

  • Type:Notice
    Citation:86 FR 11329
    Reading Time:less than a minute

    Sigma Aldrich Research Biochemicals, Inc. has applied to the Drug Enforcement Administration (DEA) to become registered as a bulk manufacturer of controlled substances. The public is invited to submit comments or objections and request a hearing by April 26, 2021. The application was submitted on December 17, 2020, and aims to manufacture reference standards of certain controlled substances. Comments should be sent to the DEA at the address provided in the notice.

    Simple Explanation

    Sigma Aldrich Research Biochemicals wants permission to make certain types of special medicines and is asking for public feedback by April 26, 2021. They need to follow the rules to make sure the medicines are handled safely, and people can ask questions or share their thoughts with the DEA.

  • Type:Notice
    Citation:90 FR 11998
    Reading Time:about a minute or two

    Sigma Aldrich Research Biochemicals Inc. has applied to the Drug Enforcement Administration to become a registered bulk manufacturer of certain controlled substances. The company intends to produce these substances for use as reference standards only, and no other uses are approved under this registration. The public can submit comments or objections electronically regarding this application until May 12, 2025, through the Federal eRulemaking Portal. Additionally, requests for a hearing on the application must also be made by this date.

    Simple Explanation

    Sigma Aldrich Research Biochemicals Inc. wants permission to make certain special chemicals that are controlled by the law, and people can say what they think about it online until May 12, 2025.

  • Type:Notice
    Citation:90 FR 9733
    Reading Time:about a minute or two

    Patheon API Inc. has applied to the Drug Enforcement Administration to register as a bulk manufacturer of several controlled substances. The registration would allow the company to import these substances as reference standards for research and development in its API Manufacturing operations. Interested parties, including current registered bulk manufacturers, can submit comments or objections electronically by April 21, 2025, and may also request a hearing on the application by the same date. Comments submitted will be tracked, and successful submissions will receive a Comment Tracking Number.

    Simple Explanation

    Patheon API Inc. wants permission to make special medicines, and people can share their thoughts about it until April 21, 2025. They need to let an official group called the Drug Enforcement Administration know what they think and follow some rules to do so.